MHRA Responsible Person (import) guidance
Acting as a Responsible Person (import)
Current edition
Last updated 22 December 2021
Current edition
Last updated 22 December 2021
About this standard
Describes how a Responsible Person (import) confirms QP certification and independent batch release certificates for medicines imported into Great Britain from approved countries.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
United Kingdom
- Batch testing and QP certification of medicines imported into Great BritainLot release and sample testing · Local test (some cases)
- Independent batch release of vaccines and blood or plasma productsLot release and sample testing · Sample testing
Related standards: EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, MFDS national lot release regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, RDC 944/2024, SFDA lot release policy, Taiwan biological product lot release regulations. See all standards.